Gliquidone
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| N-(cyclohexylcarbamoyl)-4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]benzenesulfonamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | C |
| Legal status | POM (UK) |
| Routes | Oral |
| Pharmacokinetic data | |
| Excretion | 95% Biliary, 5% Renal |
| Identifiers | |
| CAS number | 33342-05-1 |
| ATC code | A10BB08 |
| PubChem | CID 91610 |
| DrugBank | DB01251 |
| ChemSpider | 82719  |
| UNII | C7C2QDD75P |
| KEGG | D02430 |
| ChEMBL | CHEMBL383634 |
| Chemical data | |
| Formula | C27H33N3O6S |
| Mol. mass | 527.634 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
|
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehriger Ingelheim, Germany.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
